You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TAK-228

Showing 1 - 25 of 370
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Soft-tissue Sarcoma Trial in Philadelphia (TAK-228)

Terminated
Has Results
  • Soft-tissue Sarcoma
  • TAK-228
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Sep 19, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial in Houston (Laboratory

Completed
  • Advanced Malignant Solid Neoplasm
  • +3 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 21, 2022

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage III Lung Non-Small Cell Cancer AJCC v7

Active, not recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +5 more
  • Laboratory Biomarker Analysis
  • +3 more
  • New Haven, Connecticut
  • +4 more
Jan 27, 2023

Advanced Solid Tumor Trial in Sioux Falls (paclitaxel, TAK-228, TAK-117)

Active, not recruiting
  • Advanced Solid Tumor
  • Sioux Falls, South Dakota
    Avera Cancer Institute
Aug 24, 2021

Estrogen Receptor Positive Breast Cancer Trial in Houston, Sugar Land (TAK-228, Tamoxifen)

Completed
Has Results
  • Estrogen Receptor Positive Breast Cancer
  • Houston, Texas
  • +2 more
Aug 27, 2021

Advanced Nonhematological Tumors Trial in Japan, Korea, Republic of, Taiwan (TAK-228)

Terminated
Has Results
  • Advanced Nonhematological Neoplasms
  • TAK-228
  • Kashiwa-shi, Chiba-Ken, Japan
  • +3 more
Apr 22, 2021

Recurrent Lung Squamous Cell Carcinoma, Stage IV Lung Squamous Cell Carcinoma AJCC v7 Trial in United States (Laboratory

Completed
Has Results
  • Recurrent Lung Squamous Cell Carcinoma
  • Stage IV Lung Squamous Cell Carcinoma AJCC v7
  • Laboratory Biomarker Analysis
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Mar 16, 2022

Recurrent Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8 Trial in Houston

Active, not recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Leptomeningeal Tumor, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain Trial in United States

Recruiting
  • Leptomeningeal Neoplasm
  • +6 more
  • Duarte, California
  • +6 more
Dec 29, 2022

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinosarcoma Trial in Germany, United Kingdom (Paclitaxel, TAK228)

Active, not recruiting
  • Ovarian Cancer
  • +9 more
  • Berlin, Germany
  • +14 more
Mar 10, 2022

Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 Trial (Nivolumab,

Withdrawn
  • Lung Non-Small Cell Carcinoma
  • +12 more
  • (no location specified)
May 24, 2022

Breast Cancer Trial in Lebanon (TAK-228, Letrozole)

Withdrawn
  • Breast Cancer
  • Lebanon, New Hampshire
    Dartmouth Hitchcock Medical Center
Mar 10, 2020

Lymphoma Trial in Houston (TAK228, Blood Sugar Testing)

Terminated
Has Results
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 3, 2020

Advanced Nonhematologic Malignancies Trial in Spain, United Kingdom, United States (TAK-228, TAK-117)

Completed
Has Results
  • Advanced Nonhematologic Malignancies
  • Boston, Massachusetts
  • +4 more
Oct 7, 2019

Clear-cell Metastatic Renal Cell Carcinoma Trial in Worldwide (Everolimus, MLN0128, MLN1117)

Completed
Has Results
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Los Angeles, California
  • +35 more
Nov 18, 2021

Advanced Solid Tumors Trial in United States (Sapanisertib)

Completed
Has Results
  • Advanced Solid Tumors
  • Sarasota, Florida
  • +4 more
Feb 18, 2020

Endometrial Tumors Trial in Worldwide (Paclitaxel, Sapanisertib, MLN1117)

Completed
Has Results
  • Endometrial Neoplasms
  • Birmingham, Alabama
  • +77 more
Oct 28, 2021

Prostate Cancer Trial in United States (TAK-700, Bicalutamide)

Active, not recruiting
Has Results
  • Prostate Cancer
  • Birmingham, Alabama
  • +559 more
Dec 5, 2022

Primary Immunodeficiency Diseases (PID) Trial (TAK-881)

Not yet recruiting
  • Primary Immunodeficiency Diseases (PID)
  • TAK-881
  • (no location specified)
Oct 4, 2023

NSCLC Trial in Worldwide (TAK-788)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Birmingham, Alabama
  • +56 more
Jan 23, 2023

Narcolepsy Type 1, Narcolepsy Type 2 Trial (TAK-861)

Not yet recruiting
  • Narcolepsy Type 1
  • Narcolepsy Type 2
  • (no location specified)
Mar 31, 2023

Renal Impairment, Healthy Volunteers Trial in Miami, Orlando, Chicago (TAK-279)

Not yet recruiting
  • Renal Impairment
  • Healthy Volunteers
  • Miami, Florida
  • +2 more
Aug 8, 2023

Hepatic Impairment, Healthy Volunteers Trial in Miami, Orlando, San Antonio (TAK-279)

Not yet recruiting
  • Hepatic Impairment
  • Healthy Volunteers
  • Miami, Florida
  • +3 more
Jul 28, 2023

Tumors, Lymphoma, Hematologic Tumors Trial in Ukraine, United States (TAK-981)

Recruiting
  • Neoplasms
  • +2 more
  • La Jolla, California
  • +15 more
Dec 7, 2022

Healthy Volunteers Trial in Tempe (TAK-279, Erythromycin, Phenytoin)

Not yet recruiting
  • Healthy Volunteers
  • Tempe, Arizona
    Celerion - Tempe, AZ Site
Aug 9, 2023